Final-Program-ATS-2023-AP.vp

144

MONDAY • MAY 22

920 A Qualitative Interview Study to Explore the Use of Adverse Event Mitigation Strategies Among Adults Receiving Amikacin Liposome Inhalation Suspension (ALIS) in Real World Settings/ J. Ali, New Orleans, LA 921 Validating the BACES Mortality Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease/ M. Yan, Toronto, Canada 922 Mycobacterium Gordonae in People With Bronchiectasis: More Than Just Contamination?/ D. Condit, Farmington, CT 923 Peroxisome Proliferator Activated Receptor g Coactivator-1 a (PGC-1 a ) Activation to Enhance Macrophage Immune Function in Nontuberculous Mycobacteria (NTM) Infections/ J.R. Frandsen, Omaha, NE 924 Pseudomonas Aeruginosa and Bronchiectasis: Pathogenicity and Immune Response in Patients Exacerbated and Not Exacerbated®. Cabrera, Barcelona, Spain

906 Prevalence of Non-tuberculous Mycobacterial Infection in Chronic Obstructive Lung Disease Patients With Abnormal Alpha-1 Antitrypsin Genotypes/ R. Werne, Miami, FL 907 Radiological Pleuroparenchymal Fibroelastosis Pattern in Nontuberculous Mycobacterial Pulmonary Disease: A Multicenter Retrospective Study/ H. Tanaka, Tokyo, Japan 908 Computer-aided Detection Chest X-ray Findings in People With Culture-confirmed Pulmonary Tuberculosis Versus Non-tuberculous Mycobacteria Infection in a Low-TB Incidence Setting/ C. Geric, Montreal, Canada 909 Diagnosis of Mycobacterium Avium-intracellulare Complex (MAC) by Bronchial Lavage Fluid Combined With the Titers of Anti-glycopeptidolipid-core IgA Antibodies in the Sera of the Patients Suspected Pulmonary MAC Diseases/ M. Seki, Hidaka City, Japan 910 Identification by Lipid Finger-print-based MALDI-TOF Method Using Biotyper Sirius for the Diagnosis of Mycobacterium Abscessus Complex/ Y. Hoshino, Tokyo, Japan 911 Development of Subspecies-level Identification and Drug Resistance Prediction System for Mycobacterium Abscessus Species Using Multi-locus Sequence Typing/ W. Arakaki, Nishihara, Japan 912 Development of an Nontuberculous Mycobacteria (NTM) Chest CT Score to Improve NTM-pulmonary Disease Diagnosis in Cystic Fibrosis/ S.L. Martiniano, Aurora, CO 913 Clinical Features of Dominant Circulating Clones of Mycobacterium Abscessus Species in Non-cystic Fibrosis Patients in Japan and Taiwan/ T. Kinjo, Nishihara, Japan 914 Clinical Features of Bronchiectasis Patients With Rheumatoid Arthritis: An Analysis of the Bronchiectasis Research Registry/ L. Sullivan, San Diego, CA 915 Hypertonic Saline Use in Patients With Bronchiectasis: Analysis From the United States Bronchiectasis and NTM Research Registry/ A. Basavaraj, New York, NY 916 Sarecycline Pharmacokinetics-pharmacodynamics in the Hollow Fiber Model of M. Avium Complex/ S. Singh, Tyler, TX 917 In Vitro Susceptibility Testing of Imipenem- Relebactam and Tedizolid Against Australian Mycobacterium Abscessus Isolates/ A.J. Burke, Brisbane, Australia 918 Variables Associated With Antibiotic Treatment Tolerance in Patients With Mycobacterium Avium Complex Lung Disease: A Retrospective Chart Review/ M. Marmor, Stanford, CA 919 The Clinical Course of Mycobacterium Avium Complex Pulmonary Disease With Bacterial Co-infection at Diagnosis/ M. Ito, Kiyose, Tokyo, Japan

BEHAVIORAL • CLINICAL • TRANSLATIONAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION

B29

EXCITING DEVELOPMENTS IN PULMONARY REHABILITATION

9:00 a.m. - 11:00 a.m.

Walter E. Washington Convention Center Room 144 A-C (Street Level)

Viewing

9:00-9:45

Summaries/Discussion 9:45-11:00 Chairing: R.A. Evans, MBChB, FRCP, PhD, Leicester, United Kingdom A.W. Jones, PhD, Melbourne, Australia 301 A Synchronous, Virtual Pulmonary Rehabilitation Program Is Safe and Efficacious, and Expands Geographic Catchment/ E.S. Wan, Boston, MA 302 Assessment of Airway Clearance Therapy Usage and Outcomes in Post-operative Care - A Real World Evidence Study/ J. Suggett, London, Canada 303 Outpatient Pulmonary Rehabilitation in Lung Transplant Candidates With Pulmonary Arterial Hypertension/ M. Munawar, Toronto, Canada 304 Regular Exercise Interventions Support Cognitive Function Gain and Maintenance in Older Individuals With Stable COPD: A Scoping Review/ D.E. Baez, Kingston, RI 305 Performance of Pulmonary Rehabilitation in a National Severe Asthma Cohort/ I. Jarosch, Schoenau am Koenigssee, Germany

ATS 2023 • Washington, DC